A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy
Latest Information Update: 24 Jun 2024
At a glance
- Drugs Imiquimod (Primary)
- Indications Bladder cancer; Carcinoma; Urogenital cancer
- Focus Adverse reactions
- 18 Jun 2024 Planned End Date changed from 31 Aug 2024 to 31 Aug 2025.
- 18 Jun 2024 Planned primary completion date changed from 31 Aug 2024 to 31 Aug 2025.
- 04 Jan 2024 Status changed from recruiting to suspended for interim analysis.